[Evaluation of the LightCycler® SeptiFast test in newborns and infants with clinical suspicion of sepsis].

Introduction: Neonatal sepsis is a significant cause of morbidity and mortality. Early diagnosis and prompt antimicrobial therapy are crucial for a favorable outcome of the newborn child. Blood culture, the current "gold standard" method for diagnosing bloodstream infections, has a low sensitivity in newborns.